Other than the few medical centers who pioneered the migration to PACS, most hospitals lack the internal expertise to develop a comprehensive digital imaging business plan, create medical imaging architectures, select vendors, and implement PACS.Many
Other than the few medical centers who pioneered the migration to PACS, most hospitals lack the internal expertise to develop a comprehensive digital imaging business plan, create medical imaging architectures, select vendors, and implement PACS.
Many processes such as vendor selection and implementation are done only once, and developing such one-time experience in-house would be wasteful and inefficient, according to Wesley N. Bridgewater, senior business director in the department of radiology at Children's Hospital Medical Center (CHMC) in Cincinnati.
"It is highly unlikely that an inexperienced hospital-based group undertaking their first and only PACS project will be able to match the depth of a well-organized consulting group with prior experience," he said.
Before selecting a consultant, however, Bridgewater said the hospital needs to ask itself a few questions:
Then, once consultants are engaged, the organization can find ways to maximize effectiveness and minimize expense by following a few of the guidelines used by CHMC.
"Hospital leadership should dictate the consultants' mandate," Bridgewater said. "The organization must clearly state in writing its expectations of the consultant before work begins."
CHMC used the following rules of engagement during its consulting relationship with First Consulting Group:
Institutions are likely to find a relationship with a PACS consultant indispensable. Since PACS technology and industry alliances are constantly changing, consultants can energize a PACS project by providing unique resources, including deep installation expertise, a methodology for fast-tracking the initiative, and an address book bulging with industry contacts.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.